Advancing primary care with essential peer-reviewed research and insights into CNS disorders
Page 141
More Articles from The Primary Care Companion for DNS Disorders
Article
Improvement in Functional Outcomes With Adjunctive Aripiprazole Versus Placebo in Major Depressive Disorder: A Pooled Post Hoc Analysis of 3 Short-Term Studies
December 20, 2012
A potential treatment option for residual depression is to add a low-dose antipsychotic to an antidepressant regimen. In this article, Fabian and colleagues analyzed data from 3 similarly designed…
Article
Collaborative Care for the Treatment of Depression in Primary Care With a Low-Income, Spanish-Speaking Population: Outcomes From a Community-Based Program Evaluation
December 6, 2012
This retrospective study by Sanchez and colleagues evaluated the effectiveness of a grant-funded, multidisciplinary collaborative care program in a primary care setting that serves a predominantly Hispanic, low-income patient…
Letter to the Editor
Two Instances of Improvement in Tardive Dyskinesia After Administration of Aripiprazole in a Single Patient
November 29, 2012
This Letter to the Editor reports the case of a 68-year-old woman who had improvement in tardive dyskinesia with an antidepressant and aripiprazole as adjunctive therapy.
Article
Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials
November 22, 2012
Patients with depression often do not respond to the initial treatment and clinicians must then adjust therapy. The objective of this study was to determine whether switching within or…
Article
Importance of Gender in the Treatment of Schizophrenia
November 15, 2012
The authors of this study compared male and female patients participating in e-STAR (electronic Schizophrenia Treatment Adherence Registry), an international, prospective, observational study assessing use of risperidone long-acting injection…
Brief Report
Beneficial Effects of the Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia in Patients With Postpsychotic Depressive Disorder of Schizophrenia: Report of 5 Cases
November 8, 2012
Tardive dyskinesia (TD) is characterized by involuntary, repetitive, purposeless movements that can affect different parts of the body. Tardive dyskinesia is a well-known side effect of conventional antipsychotics and…
